Strategic alliance of Hanson Research, Shimadzu and Solvias AG improves dissolution testing workflow.
Los Angeles, CA, October 21, 2015 (Newswire.com) - Hanson Research, a privately held Southern California technology company which focuses primarily on developing high tech instruments for pharmaceutical dissolution and diffusion testing, has selected ARGUS/Dissolution as the PC software platform to control the upcoming Hanson/Shimadzu on-line UV system.
Hanson has already formed a strategic alliance with Shimadzu to offer dissolution users an on-line automated system which consists of Hanson Vision dissolution testers and autosamplers with the Shimadzu UV-1800. The instrument offering will be tied together with the ARGUS/Dissolution PC software which is said to be robust, scalable, user-friendly and 21 CFR Part 11 compliant, the latter being a critical requirement of dissolution users today.
"Dissolution analysts require system flexibility and ease of use. Some pharmaceutical products only require simple, straightforward testing while other products have quite complex methods. Our instruments are designed to accommodate both ends of the spectrum. The challenge was to provide a software product that takes advantage of our instrument's great features and capabilities which users rely on. ARGUS/Dissolution hit that target perfectly. And because the software was developed by dissolution industry users, the security compliance is probably the best in the business".
Keith Hamman, President of Hanson Research
Solvias AG, a privately held analytical and chemical development company based in Switzerland, developed ARGUS/Dissolution as an all-in-one software solution covering the entire dissolution workflow from data acquisition to the release of the spectrophotometric results.
According to Hanson Research President, Keith Hamman, Hanson chose ARGUS software not only because of the software’s ability to utilize the advanced capabilities of the Vision tester and autosampler but because of its audit-proof compliance. “Dissolution analysts require system flexibility and ease of use,” said Hamman. “Some pharmaceutical products only require simple, straightforward testing while other products have quite complex methods. Our instruments are designed to accommodate both ends of the spectrum. The challenge was to provide a software product that takes advantage of our instrument’s great features and capabilities which users rely on. ARGUS/Dissolution hit that target perfectly. And because the software was developed by dissolution industry users, the security compliance is probably the best in the business”.
Says CEO of Solvias, Karen Huebscher, "We at Solvias are excited about the cooperation with Hanson Research - a company that is contributing high quality equipment to the dissolution market for so many years.”
Hanson’s on-line UV system, with the Shimadzu UV-1800 and ARGUS/Dissolution software, will be launched at the American Association of Pharmaceutical Scientists (AAPS) annual meeting and expo in Orlando, FL on October 25, 2015. For more information, visit Hanson Research at AAPS Booth #1340.
ABOUT HANSON RESEARCH
Hanson Research is a global technology company that specializes in analytical test instruments for the pharmaceutical industry. Founded by the innovator of modern dissolution test technology, Hanson Research helps ensure the world’s pharmaceuticals are pure, safe, and effective by manufacturing equipment that sets the global standard for quality, innovation, and long-term value. Hanson instruments are used by scientists in over 75 countries worldwide and are supported by the industry’s top customer service team. For more information, please visit www.hansonresearch.com.
CONTACT
Sara Hanson
Hanson Research Corp.
pr@hansonresearch.com
Share: